Oceania Healthcare Limited logo

Building on Momentum

Full Year Results21 May 2025OCAHealthcare

MEDIA RELEASE
22 May 2025

FY25 Result – Building on momentum

Oceania Healthcare (NZX: OCA) reported underlying EBITDA of $86.0m for the year ended 31 March

2025, up 4.1% on FY24, reflecting steady sales momentum and stock sell down. Building on this

momentum, the company has signalled a sharpened strategy centred on strengthening its foundation,

enhancing efficiency, and setting the stage for accelerating growth.

Financial summary and highlights

• Total comprehensive income of $74.6m (FY24: $70.5m).

• Reported NPAT of $30.4m (FY24: $31.5m).

• Underlying EBITDA rose to $86.0m, up 4.1% on FY24.

• Underlying NPAT was $52.5m, (15.5%) lower than FY24, a result of interest charges on

completed developments no longer able to be capitalised.

• Operating cashflow increased to $110.3m, up 6.7% from FY24.

• Total assets increased to $2.9b, a $158m increase on FY24 largely a reflecting the completion

of Elmwood, Waterford and Awatere alongside fair value movements due to the sell down of

independent living units at other sites.

• Debt gearing reduced to 36.3%, down from FY24’s 38.3%. All banking covenants were met.

• Realised capital gains rose to $83.2m, an increase of 22.6% on FY24.

• Premium care revenue was up 12.5% on FY24, reaching $25.4m.

• Total sales volume at The Helier increased 100% from FY24, with 24 apartments and care

suites sold in FY25 and full development cost recovery expected by FY26.

• A broader business optimisation programme is underway, targeting $15m to $20m of cost

savings with full benefits realised in FY27.


Steady sales momentum

Sales momentum accelerated in the second half of FY25, with new sales volumes increasing by

17.2% and resales up 5.3% on prior year, notwithstanding market conditions. This growth was driven

by a revitalised sales and marketing approach, refined pricing strategies, and enhanced leadership in

sales.

Strong sell down results were achieved across key development sites. Occupancy increased at The

Helier in Auckland with 41% occupancy as at 20 May 2025 compared to 14% as at 31 March 2024.

Additionally, Oceania successfully completed the full sell down of independent living apartments at

The Bellevue in Christchurch shortly after year end, within just 24 months. The new care suite centre

at Redwood in Blenheim has reached 62% occupancy in record time with expectations to be fully

occupied within 12 months.

Financial performance

Total sales volumes were up 9.2% on the prior corresponding period (pcp), including a 17.2% uplift in

new sales volumes to 184 independent living units (ILUs) and care suites.

Operating cash flow increased to $110.3 million, a 6.7% rise compared to $103.4m in FY24. This was

driven by higher cash receipts from occupation right agreements, up 30.1% on pcp, reflecting key

drivers such as improved settlement timing, reduced unsold stock, and increased care revenue.

Underlying NPAT was $52.5m for the 12 months ended 31 March 2025. This included total capital

gains of $83.2m, an increase of $15.3m or 22.6% on the previous year.

Chair, Liz Coutts noted “As at 31 March 2025, undrawn net debt headroom was $97.0m and gearing

reduced to 36.3%, down from 38.3% as at 31 March 2024. This improvement reflects continued

capital discipline, divestment of non core assets, a sharpened sales focus and a targeted cost

optimisation programme.”

In March 2025, Oceania successfully refinanced its syndicated banking facilities, extending debt
maturities and securing competitive terms with unchanged covenant conditions. The refinancing,

supported by existing lenders ANZ, ASB, ICBC, and new lender BNZ, underscores lender confidence

and positions Oceania for ongoing growth.

Final Dividend

Ms Coutts announced that “The Directors have resolved not to declare a final dividend. Work is

underway to review our Dividend Policy so that it better aligns with the operating cashflows of the

business. Our revised Dividend Policy will be announced at the time of the ASM in June.”

Stabilising the core

In FY25, Oceania initiated an operational optimisation programme to realign the business and support

its future strategy. This has already delivered $5m in cost savings, which will be realised in FY26.

Suzanne Dvorak, CEO said “We initiated a right sizing programme in FY25 to reshape the business

and align with Oceania’s future strategy. To date this programme has implemented cost savings of

$5m that will be realised in FY26. Building on this, a broader business optimisation programme is

underway, targeting $10m to $15m of sustainable annualised savings. So far in FY26, a further $5.2m

of cost savings have been identified with benefits to be realised from 2HY26. Full benefits will be

realised in FY27, with a focus on system consistency, margin discipline, and operational simplicity.”

Over the next 12 months, Oceania will continue to sharpen execution, reinforce leadership capability,

and ensure the business is well positioned to activate its new strategy from FY27.

Setting our strategic direction

The Board has approved a new strategic direction to guide Oceania through the next five years.

Developed through deep engagement with the Board, executive team, employees, and independent

consumer research with residents and families. It reflects both the lessons of the past and a clear

vision for the future. Oceania’s refreshed purpose — “Supporting and empowering people to live well

as they age” — serves as the anchor for our next strategic phase. While grounded in Oceania’s

existing strengths, this is not a simple extension. It is a sharper and more ambitious plan, designed to

meet changing resident expectations, increasing care needs, and a more complex operating

environment.

Ms Dvorak added “Our strategy is structured around four refined focus areas — Connected Care,

Inspired Living, Empowered People, and Purposeful Impact — the strategy will guide planning,

investment, and operational decision making across the business.”

This strategic direction positions Oceania to lead with clarity and confidence, supported by a strategy

that is practical, measurable, focussed on creating value for our shareholders and is aligned with what

matters most: people, purpose, and performance.”

The full five year strategy will be further communicated in the coming months.

ENDS

For all enquiries, please email investor@oceaniahealthcare.co.nz or phone 0800 333 688

---

22 MAY 2025
Results presentation

for the year ended

FY25

1
Key messages

•Strategic sales focus and incentive programme provides

sales momentum

•Successful bank refinance shows support of banking

syndicate

•Unsold stock remains the largest lever to reducing debt

•Development to focus on villas in the medium-term to

retain flexibility

•Enhancement plan strengthens business before launch

of new strategy

2
Total Sales Volume

520 units

Increaseof

9.2%

From 476 units in FY24

Total Comprehensive Income

$74.6m

Increaseof

5.8%

from $70.5m in FY24

Financial summary

Oceania delivered a solid financial result in FY25 with an increase in underlying EBITDA and sales volumes, despite market conditions.

Delivering to strategy

1. A reconciliation to the reporting statutory figures is included in Appendix 01.

2. Restated in prior periods, this restatement increases Operating Cashflow from $85.4m in March 2024. Refer to note 1.2(ii) of financial statements.

Operating Cashflow

$110.3m

Increaseof

6.7%

from $103.4m

2

in FY24

ORA Receipts

$294.5m

Increaseof

30.1%

from $226.3m in FY24

UnderlyingEBITDA

1

$86.0m

Increaseof

4.1%

from $82.6m in FY24

Dividend

The Directors have resolved not to declare a final dividend. Work is underway toreviewour Dividend Policy so that it better aligns

withthe operating cashflows of the business. Our revised Dividend Policy will be announced at the time of the ASM in June

Total Assets

$2.9b

Increaseof

5.7%

from $2.8b in FY24

3
Operational highlights

Solid progress in sales execution was demonstrated, and an operating model optimisation programme wasinitiated toimprove investor returns.

1. Care occupancy for the entire portfolio increased to 92.3% from 91.1% FY24.

•Total new sales volumes at The Helier increased 100% from

FY24, with 24 apartments and care suites sold in FY25

•Total development cash cost recovery of The Helier expected

by FY26 (including land and finance costs)

•Awatere and Waterford developments completed in FY25 with

forecast cash recovery on first sell down in aggregate

•>90% of apartments at The Bellevue sold within 18 months of

opening, with the final 3 scheduled to settle within 3 months

•Record sell down rate of new care suite development site.

Redwood 62% occupied within 12 months of opening

•Care occupancyfor sites not affected by development

1


increased to 94.5% from 92.6% FY24

Business overview

5
Strong ILU and care suite sales performance

across both new and existing stock

41% total occupancy

1

at The Helier, increased from

14% at FY24

Partnership with Marketability at The Helier has

delivered an increase in 2HY25 ILU sales vs

1HY25

Sales incentives have assisted to increase new

sales volumes, up 17.2% on FY24

43 of 46 apartments at The Bellevue sold down in

18 months since opening in September 2023

Average sales prices (new sales)

NZD000s

Sales volumes

1. Total occupancy at The Helier includes both apartment and care residents (including respite) as at 20th May 2025. Occupancy as at 31 March 2025 was 36%.

Sales update

Total sales volumes increased 9.2% from FY24, driven by the execution of selling down unsold stock.

FY25FY24FY23

Resales

New sales

Focus on sales execution

599

1,135

1,032

1,108

334

373

356

FY23FY24FY25

98

182

129

190

130

206

54

74

89

68

97

87

152

256

218

258

227

293

Average sales prices (resales)

NZD000s

468

361

425

520

578

618

208

283

283

FY23 FY24 FY25

VillaApartmentCare Suite

6
9.2%

increase in total sales

volumes YoY

17.2%

increase in new sales

volumes YoY

Awatere

28%

*Revenue recognition policy remains consistent with prior years. ORA sales are only recognised when a contract becomes unconditional and has either cooled off or the resident has occupied the unit.

Strategic sales focus

Additional tools outside of pricing adjustments to increase sales volumes.

Sales focus

Impact

Alignment: accountability, alignment and

appropriate sales incentives for the sales

team

Centralised pricing office: managed by

the finance function to increasethe

frequency of unit pricing reviews and

ensureoptimum pricing

Resident incentives: cash incentives,

furniture packages and moving costs have

been used in a targeted manner

The Helier

113%

Increases in new ILU sales volumes (year on year)

The Bellevue

61%

The Bayview

44%

7
Repositioning: A refined marketing approach introduced

to shift perceptions of The Helier as exclusively high end

and expensive. Messaging now emphasises ‘affordable

luxury’ in a connected community, supported by well

positioned weekly pricing

The Helier marketing

Prioritising marketing spend to drive quality leads.

The Helier

Early Performance Indicators:

190% increase in qualified leads from

31-Jan to 31-Mar vs PCP

450% increase in website traffic from

31-Jan to 31-Mar vs PCP

8
DevelopmentscompletedinFY25

Completion* of all high density developments under construction, the FY26 focus is getting construction ready villa products.

A total of 224 units were delivered in FY25, made up of 106 care suites and 118 apartments.

50

Apartments

completedinDec-24

*Meadowbank dementia will welcome residents in May 2025.

Elmwood, Auckland

106

Care suites

completedinSep-24

Build Costs c. $55m

-$4.0m units sold

-55% of 22 units available for sale sold

-Remaining units occupied with

transferred residents

Build Costs c. $50m

-$9.5m units sold

-16% of units sold

Waterford, Auckland

Awatere, Hamilton

Stage2-Apartments

completedinMay-22

63

Build Costs c. $55m

-$5.1m units sold. 7% of units sold

Build Costs c. $38m

- $33.9m units sold. 76% of units sold

68

Stage3-Apartments

completedinNov-24

9
$51m

$213m

$88m

•Total unsold stock (including resale stock) of $392m, vs

$396m at Mar-24

1

•$104m of development stock remaining from Awatere,

Waterford and Elmwood at FY25

•Development stockhas reducedfrom $353m at FY24

1

to

$342m despite the addition of c. $120m ofnew stock

during FY25. Salesin the period totaled $131m

•The value of new stock over 12 months old increased

primarily due to aging stock at:

•The Helier ($112m of remaining stock), final stage

completed Feb-24, and

•The Bayview stage 3 ($40m of remaining stock), 28

apartments completed Dec-23

1.Based on CBRE Limited Valuations.

2.Units developed currently occupied by transferred residents and residents occupying care suites under a PAC.

Stock update

Sell down of new stock remainsa key focus for Oceania.

Our development stock will be used to repay development debt

FY24

1

$353m

Value of unsold new

stock unavailable for

immediate sale

2

Value of unsold new

stock completed within

the last 12 months

Value of unsold new stock

completed over 12 months

ago

KeystockmovementssinceFY24

$55m

$104m

$183m

FY25

1

$342m

c. $120m of development stock

added during FY25

Financial

11
Profit and loss

Total operating profit increased by 7.8% driven by the 48% uplift in change in fair value of IP.

1

•Fair value and impairment of IP and PPE: Increased 25.1%

from FY24 to FY25 at mature and existing villages

•Finance expenses: Finance costs increased by 26.8% primarily

due to the expensing of$10.5mofinterest on completed

developments during FY25 (FY24:nil). This was partially offset

by a loan modification gainas a result ofthe refinance

•Operating expenses: Increased 1.5%. Focused optimisation of

the operating model resulted in $5m in cost savings, to be

realised in FY26. The programme is on track torealise a further

$10-$15m in cost savings in FY27

•Business closure: With changes to the certification pathways

for overseas nurses recently introduced, a decision was made

during FY25 to close the Wesley Institute of Nursing Education,

with the final course concluding in Apr-25. Wesley contributed

EBITDA of $4.7m in FY25 and $6.8m in FY24

1. The change in fair value equates to an uplift of $29.4m or 48%. See appendix 02.

2. Includes change in fair value of IP, other revenue, rental expense in relation to ROU asset, impairment of goodwill and impairment of PPE. See appendix 02.

NZDmFY25FY24

Var

Operating revenue260.6265.5

(1.8%)

Operating expenses (260.6)(256.7)

1.5%

Change in fair value of IP, impairment of

PP&E and other

2

68.855.0

25.1%

Operating Profit68.863.8

7.8%

Finance costs(20.8)(16.4)

26.8%

Depreciation (buildings)(14.4)(12.8)

12.5%

Depreciation and amortisation (chattels

and other)

(7.7)

(6.2)

24.2%

Profit before Income tax25.928.4

(8.8%)

Taxation benefit4.53.1

45.2%

Reported Net Profit after Tax30.4

31.5

(3.5%)

Other Comprehensive Income44.2

39.0

13.3%

Total Comprehensive income74.6

70.5

5.8%

12
Trading results

Underlying EBITDA

1

increased 4.1% despite continuing to divest, driven by a 22.6% increase in capital gains.

1. This slide provides trading and underlying measures. A reconciliation to the reporting statutory figures is included in Appendix 01.

Village capital gains are strong while care costs reduce

UnderlyingEBITDA

1

Care premiumisation

$25.4m

12.5% increase

from FY24

Total

occupancy

(excl dev sites)

94.5%

UnderlyingNPAT

1

4.1% increase

from FY24

$62.1m in

FY24

22.6% increase

from FY24

Realisedcapitalgains

1

(DMF and PAC fees)

$86.0m

$52.5m

$83.2m

2.0% increase

from FY24

Key themes

Underlying EBITDA increased 4.1% despite a reduction in

operating revenue, increased expenses and continued

divestments in the period

Underlying NPAT decreased by $9.6m. A key driver for the

reduction wastheFY25 interest expense which

included$10.5m relating to interest on completed

developments(FY24 nil)

Realised capital gains have increased $15.3m since FY24,

driven by strong resale margins at Meadowbank and capital

gains from The Helier

Premium care revenue is up 12.5%, driven by our recently

completed developments at Elmwood, Lady Allum, Redwood

and The Helier

Total occupancy (not affected by development sites) is up

2.0% from FY24

13
Care segment total revenue, EBITDA and EBITDA margin (incl. capital gains) (%)

NZDm

Care dashboard

Group care occupancy continued to rise, up 1.2% since FY24. Care EBITDA per bed also increased by 2.7% YoY.

Care EBITDA per bed

NZD

Care occupancy

•Care EBITDA per bed including capital gains has increased

7.5% reflecting a modernised care portfolio

•Care suite development margin increased 7.0%, driven by

higher margin sales at The Helier

•Increase in EBITDA per bed excluding capital gains up

2.7% to $10.3k

9,044

10,106

10,374

16,639

18,033

19,385

FY23FY24FY25

Care EBITDA per bedCare EBITDA per bed including capital gains

90.4%

91.1%

92.3%

92.0%

92.6%

94.5%

FY23FY24FY25

Group OccupancyOccupancy of sites not affected by development

19.3%

18.7%

19.0%

10.5%

10.5%

10.2%

FY23FY24FY25

RevenueEBITDAEBITDA margin (cap gains incl.)EBITDA margin

14
Care business

Care business remains stable with EBITDA per bed increasing since FY24.

NZDmFY25FY24

Var

Daily care fees174.1 181.4

(4.0%)

PAC revenue7.5 6.4

17.2%

Care suite DMF17.9 16.2

10.5%

Other revenue1.6 4.2

(61.9%)

Total aged care operating

revenue

201.1 208.2

(3.4%)

Staff and resident expenses(140.2)(146.0)

(4.0%)

Occupancy and site overhead

expenses

(40.5)(40.2)

0.7%

Total aged care expenses(180.7)(186.2)

(3.0%)

Aged Care Underlying EBITDA20.422.0

(7.3%)

EBITDA per care bed / suite

10,37410,102

2.7%

Plus: Other aged care related earnings included within the

Village Segment

1

Care suite development margin9.2 8.6

7.0%

Care suite resale gains8.5 8.6

(1.2%)

Aged care related underlying

EBITDA

38.2 39.0

(2.1%)

Aged care related underlying

EBITDA per bed

19,395 18,033

7.5%

•Increase in EBITDA per bed including capital gains up 7.5%

to $19.4k

•Impact of divestments: See Appendix 03 for summarised

P&Ls of sold and exited care sites in FY25 and FY24

•Lower revenue following divestments and lower gain on

divestments (recognised in FY24 as Other Revenue)

contributed to 80% of the 3.4% aged care operating revenue

decline

•Aged care expenses decreased 3.0% in totality, but were

8.1% higher than FY24 excluding divestments, partially

driven by new care suites opening at The Helier and

Redwood

•EBITDA Impact: Aged Care Underlying EBITDA increased

4.3% excluding divestments. See normalised view in

Appendix 03

1. Development margin & resale gains on care suites are included within the Village Segment for underlying profit and statutory reporting purposes as the ORAs are issued by Oceania Village Company Limited. As these margins are in lieu of daily premium charges

under the traditional model, these earnings are aggregated above to present a more complete picture for the Care segment.

15
•Village weekly fees are now index linked for new

ORAs, resulting in a $15m valuation gain at HY25

•Strong development margins: The value of

development margins increased 36.4%, taking the

average capital gain to 36% as a result of elevated

sales performance at The Helier, Bellevue and

Redwood

•Sales volumes: increased by 9.2% (520 vs. 476

units). Notably a large increase in new sales of 17%

•Care suite total sales increased by 13.6% from

FY24, with new care suite sales increasing by 27.9%

and resales increasing by 8.4%

38%

31%

36%

31%

29%

28%

FY23FY24FY25

Development MarginResale Margin

Sales volumes

Our retirement villages

Total saleshave increased on FY24, as we continue to execute on our sales targets.

FY25FY24FY23

Development and resale margins

ResalesNew sales

98

182

129

190

130

206

54

74

89

68

97

87

152

256

218

258

227

293

16
Retirement village business

Increase in sales volumes leads to a 13.7% increase in Retirement Village Underlying EBITDA.

1.This slide provides trading and underlying measures. A reconciliation to the reporting statutory figures is included in Appendix 01.

2.Other revenue in FY24 included $2.7m of insurance income relating to Lady Allum.

NZDmFY25FY24

Var

Villa and Apartment DMF39.5 38.6

2.3%

Retirement village service fees10.8 9.7

11.3%

Other revenue

2

3.3 4.6

(28.3%)

Total retirement village

operating revenue

53.6 52.9

1.3%

Realised gains on resales34.832.5

7.1%

Realised development margin48.3 35.4

36.4%

Total retirement village

expenses

(40.3)(36.1)

11.6%

Retirement village underlying

EBITDA

96.484.8

13.7%

Total resale volume336 319

5.3%

Total new sales volume184 157

17.2%

Total sales volume520 476

9.2%

Less: Aged care related earnings included within the Village

Segment

Care suite development margin &

resale gains

(17.8)(17.2)

3.5%

Retirement village underlying

EBITDA (ex care)

78.667.6

16.3%

•Resale margins grew 7.1% on pcp, driven by ILU resale

margins of $8.0m at Meadowbank

•Development margin increased 36.4%, driven by sales at

The Helier, The Bellevue and Redwood (contributing

c.$35m)

•Retirement village underlying EBITDA grew 16.3% ex

care: driven primarily by resale and capital gains

83.0

84.8

96.4

FY23FY24FY25

Retirement village underlying EBITDA

1


($m)

17
Cash flow

Cash flow from operating activities increased by 6.7%, $110.3m in FY25 compared to $103.4m for FY24.

1. Restated in prior periods, this restatement increases Operating Cashflow from $70.2m to 78.8m in March 2023 and $85.4m to $103.4 in March 2024. Refer to note 1.2(ii) of financial statements.

NZDmFY25FY24Var

Receipts from residents for village and care fees201.0 207.9

(3.3%)

Payments to suppliers and employees(266.1)(241.6)

10.1%

Net occupational rights agreements187.9 147.5

27.4%

Net interest, goods and services tax and other(12.5)(10.4)

20.2%

Net cash inflow from operating activities110.3 103.4

1

6.7%

Payments for PPE and intangible assets(39.9)(52.0)

(23.3%)

Payments for IP and IP under development(73.7)(128.4)

(42.6%)

Interest paid in relation to development borrowings(18.4)(18.0)

2.2%

Proceeds from sale and / or disposal of PP&E and IP31.6 19.2

64.6%

Net cash outflow from investing activities(100.3)(179.2)

1

(44.0%)

Net borrowings(8.4)84.8

(109.9%)

Principal Payment for lease liabilities(1.5)(2.1)

(28.6%)

Dividend paid- (6.8)

-

Net cash inflow from financing activities (9.9)75.9

(113.0%)

Net increase in cash and cash equivalents0.1 0.1

0.0%

Cash and cash equivalents at beginning of the period7.5 7.4

1.4%

Cash and cash equivalents at end of the period7.6 7.5

1.3%

•Development capital expenditure reduced $54.7m as

FY25 saw completion of remaining high density

developments

•Net cashflow from operating activities has increased to

$110.3m from FY24 largely attributed to a net 27.4%

increase in new occupation right agreements

Net cash flow from operating activities

1


($m)

78.8

103.4

110.3

FY23FY24FY25

18
34.9

34.4

51.9

60.4

86.8

94.8

Development debt from projects

under construction and land purchases

Value of related land assets and WIP

LandWIP

1.Development debt balance includes The Helier, Elmwood care suites, Redwood care suites, Waterford apartments and Awatere apartments (Stage 3).

2.The estimated value of 44 care suites (which are occupied by ORA transfers) at Elmwood. These units are not currently valued as unsold stock, but will be used to repay development debt once the transferred ORA resident vacates and the unit is sold.

3.The future and current development debt and associated value includes the land at Franklin, Bream Bay, Gracelands and Woodlands, plus WIP balances at Franklin and Meaadowbank. The cost of land purchased at Gracelands and Woodlands was funded by facility A/core debt.

Future cash recycling

Oceania’s debt is primarily development related, supported by current and future new sales stock, providing a clear path to debt repayment. In

aggregate we have $146m of asset coverage to our current development related debt.

Development debt from completed (but not yet fully repaid)

1


developments to underlying development assets (NZDm)

Development debt – future and current developments

•$8m / 1.09x coverage from land and WIP values

•Faster cash recycling from villa products in the medium term

Development debt – completed sites in sell down

•Our unsold new stock will be used to repay development debt, with

excess proceeds of $138m available to pay down working capital

borrowings or additional development borrowings

Development debt from land purchases and developments under

construction

3

to underlying development assets

3

(NZDm)

2

3

3

1

218.4

341.8

15.0

218.4

356.8

Development debt

from completed developments

Value of unsold new stock

Estimated value of 44 care suites at Elmwood

19
Balance sheet

The balance sheet has demonstrated both growth and stability, NTA per share increased 5.9% YoY.

•Covenants: All financial banking covenants met

•Gearing

1

: Gearing has decreased 5.1% to 36.3% at

FY25 from 38.3% at FY24

•Borrowings: Decrease of 2.0% reflective of sell

down of unsold stock and divestments offset by

ongoing development costs

•Asset Growth: Total assets rose $158m to $2.9b,

driven by completions of care suites at Elmwood, and

apartments at Awatere and Waterford

•Net Tangible Assets: rose by 8 cps to $1.51 cps in

FY25 from FY24

1. Gearing refers to net debt/(net debt+equity), a financial ratio that measures a reliance on debt vs equity financing.

NZ$m

FY25FY24Var

Assets

Cash and trade receivables126.1135.4(6.9%)

Property assets2,800.52,586.38.3%

Other assets14.160.7(76.8%)

Total assets2,940.72,782.45.7%

Liabilities

Refundable occupation right

agreements

1,106.8 1,004.810.2%

Borrowings627.7 640.5(2.0%)

Other liabilities104.3 110.6 (5.7%)

Total liabilities1,838.81,755.94.7%

Equity

Contributed Equity716.0 716.0 0.0%

Retained Deficit7.0(34.3)(120.4%)

Reserves378.8 344.8 9.9%

Total equity1,101.81,026.57.3%

Net tangible assets1,097.11,020.87.5%

20
125

100

500

FY26FY27FY28FY29FY30FY31

1. Oceania accounting policy, finance costs on working capital facility and in relation to completed developments recognised in NPAT. Finance costs in relation to developments under construction capitalised to WIP. Total finance costs in relation to completed developments circa $10m

for FY25.

Bank refinance - strong lender support

Successfully refinanced existing $500m debt facilities with no amendment to covenants. Effective 1 May 2025.

Split and increase in tenor provided a spread of the maturity profile of term

and retail debt

Pro-forma debt tenor profile has improved (NZDm)

Pre re-finance

125

100

50

450

FY26FY27FY28FY29FY30FY31

•Good demand from both existing and new lenders,

withoptimal pricing, reflecting a strong market

appetite for the business

•Expanded syndicate: BNZ joined the three

incumbent lenders

•No waivers or amendments to banking covenants

sought, with confidence in current and ongoing

compliance

•No new requirements forsyndicate approval of

land purchases or development commencement

•Secured line and margin fee cost savings of

estimated c.$1.0m per annum

1

Post re-finance

Retail bonds

Bank facilities

21
Covenants exceeded: ICR coverage of 3.5x

compared to the covenant of 2.0x. The covenants

were unchanged through the refinance process

Flexibility to repay debt: Oceania has the

flexibility to pay down core debt once a

development has been fully paid off

Fixed interest rates: We have $225 of retail

bonds with a blended interest rate of 2.7%,

expiring in FY28 and FY29. $50m of 3.4% interest

rate swaps expire FY27

Current average interest rate: (including margin

and hedging) on bank debt of 4.81%

Debt facilities Facility limitDrawn amount Headroom

General / corporate$185m$112.1m$72.9m

Development facility$315m$298.5m$16.5m

Retail Bonds$225.0m$225.0m-

Total limits /

borrowings

$725.0m$635.6m$89.4m

Cashn/a$7.6m$7.6m

Total net debt /

headroom

$628.0m$97.0m

Oceania holds sufficient headroom in its $725m of debt facilities, for future developments and land acquisitions, and complies with all banking

covenants.

Balancesheetmanagement

Covenants

Debt

covenant

As at

FY25

As at

FY24

Net debtn/a

$628.0m$636.5m

Net debt / (net debt + equity)n/a

36.3%38.3%

Loan to value ratio<50%

37.8%38.8%

ICR

1

≥ 2.0x

3.5x3.4x

22
1. FY25 Climate-Related Disclosure to be published in early June 2025.

Sustainability and Climate

Sustainability underpins Oceania’s strategic pillars, and we are committed to integrating thinking across the business.

Environment

Green star ILU developments: All new ILU developments are

continuing to bedesigned to NZGBC Homestar ratings

Waste target achieved in FY25: achieved a construction waste

away from landfill diversion rate of >85% for Auckland and >75%

for regional areas, exceeding targets

Reduction in absolute Scopes 1 and 2: GHG emissions by 42%

by FY2030 from a FY2022 base year: -29% (reduction against

FY2022 base year)


Social

Finalist in Sustainability Leadership Deloitte Top 200

business awards

Supported RVA sector negotiations that improve

transparency, enhance resident wellbeing and support the

long-term sustainability sector

Staff retention improved to 77.4% demonstrating the building

of a more supportive and stable workplace

Governance

Refresh: of FY27 – FY31 strategic plan

Climate transition plan

1

: providing strategic direction to reduce climate risks and build resilience by transitioning to a low-emissions future

Growth: Focus on growth and building new developments that align with the modernisation of the portfolio

Implementation: of new IT systems to create efficiencies in the workforce

E

S

G

Portfolio

24
Portfolio direction

The portfolio's evolution from IPO reflects a strategic shift focused on growth and modernisation.

•Since listing, the majority of the portfolio (88%) has been

significantly improved through acquisition and development

Since IPO in 2017, 88% of sites in the Oceania portfolio have been redeveloped or acquired, resulting in a new modern portfolio

% of sites developed or acquired since IPO (by valuation)FY17 vs FY25 Portfolio

•There has been a focus on modernising the existing portfolio

and increasing the number of independent living units

•18 sites have been sold or exited since IPO

2,580

242

1,054

3,876

1,068

1,090

2,003

4,161

Care BedsCare SuitesILUsTotal

FY17FY25

88%

12%

25
ProgresssinceMarch23:

Divestment programme

Over the course of FY25, 7 sites have been sold for aggregate proceeds of ~$35m

1

. The divestment programme will continue to consider the

portfolio’s strategic direction and appropriate use of capital.

1. Woburn was under contract as at 31 March 2025, and settled 13 May 2025.

10

sites sold

1


~$55m

from divestment

programme

(past 24 months)

Otumarama Woburn

1

Totara Park

FY25 divestments($35.5m)

Victoria Place Middlepark Holmwood Takanini

26
Developmentsunderconstruction-Meadowbank

The opening of the Dementia Building marks the sixth and final stage of a 15 year modernisation journey for Meadowbank Village.

Build cost c. $26m

40 Dementiabeds

CompletedinMay-25

•The dementia development concludes the sixth and final

stage of a key integrated Auckland site

•Innovative ORA offering for dementia suites, prices

starting from $695k

•Certification has been granted for Oceania to offer

excellent resident centered care

•The Oceania integrated enriched model of care guides

and supports residents, families, and staff

Meadowbank Offering

Total serviced apartments36

Total apartments157

Total care suites64

Total dementia suites40

Years to develop entire site>15 years

Meadowbank

Auckland

27
Developmentsunderconstruction-Franklin

Stage one of the Franklin development is set to be completed in FY26, Oceania’s first greenfield broadacre site.

Stage one build cost including community centre c. $50m

31 villas

1

Community

Centre

Full Site Statistics inclusive of new development

Total villas132

Total apartments43 (developed > 2030)

Total care & dementia units81

Years to develop entire site7-10 Years

Forecast peak development debt on sitec. $110m

Total cost of developmentc.$200m-$250m

•Village and Sales manager at Franklin appointed and

commenced April 2025

•First Oceania Homestar 7

2

villas and first Green Star

community

•Residents will receive amenity from the moment they join

the village, creating an immediate community

•3 on site showhomes are complete

Franklin

Auckland

Stageone tobe

completedinFY26

1.1 villa is currently being used as a sales office and 30 villas will be available for immediate sale.

2.The Homestar 7 rating is achieved using the new tool Version 5 (v5), which is higher specification to the previous 4.1 version.

28
High Density Developments

1.4 ha – 140 units consented

Future high density apartments

to complete the site (artistic

image shown)

The Bayview, Tauranga

1.5 ha – 120-150 units

consented

Future 20-40 dementia suites

and apartments to complete

integrated site

2.6 ha - 70 villas planned

Adjoining land was added to

this site in FY25 further

expansion of lower density

development to a mature site.

7.6 ha – 23 villas consented

Broadacre villa product with

future potential for >105 villas

and 40-60 care suites on

adjacent section

Oceania landbank

Oceania’s landbank currently includes 23.5ha of development land adjoining existing villages. Providing optionality to further develop as market

conditions improve. Some key land banks are listed below.

1.8 ha – 70-100 villas

planned


Villa product with optionality

for future apartments

Bream Bay, Ruakaka

Waterford, Auckland

0.2 ha – 60-80 care units

planned

Opportunity for care suites

completing integrated offering

Lady Allum, Auckland

Villa Developments

Elmwood, Auckland

Gracelands, Hawkes Bay

Strategy

30
Strengthening the foundations: before launching the strategy

We’re focused on executing our near term Enhancement Plan, strengthening our core ahead of full strategy rollout.

Address performance and capability pain

points

Execute on operational optimisation plan -

$15 - $20m cost savings

Tighten operational execution to drive

ongoing cashflow improvements

Consolidate and enhance our foundations

FY26 Enhancement Plan

31
1. Woburn proceeds received 13 May 2025.

Strengthening the foundations: progress update

At HY25, we set clear near term objectives for the business which have been achieved.

PrioritiesFY25 PerformanceFocus for FY26

Sales

•Total sales volumes up 9% on FY24

•New sales up 17%, resales up 5% on FY24

•24 ILU and CS sales at The Helier in FY25

•Continue improving sales cadence at sell down sites

•Reduce stock levels

•Continued upskilling of inhouse capability

Capital

Management

•Gearing reduced to 36.3% vs 38.3% in FY24

•Further reduction in gearing

•Review of Dividend Policy

Cost Control

•Right sizing programme established with

$5.0m cost savingsto be realised in FY26

•Broader business optimisation programme underway targeting

$10m to $15m of sustainable annualised savings with full

benefits to be realised duringFY27

•$5.2m of cost savingshave been actioned and will be realised

from 2HY26

•Investment in systems and software to increase operational

efficiency

Portfolio

Alignment

•$10.5m from divestment of 3 sites since

HY25

1

•Total FY25 divestment proceeds of $35.5m

relating to 7 sites

1

•Continued review of portfolio return on investment

•Continue broadacre villa developments

Our People

•Established a full executive team, that has the

expertise required for the next strategic phase

•Align operating structure to strategic objectives

32
The programme spans a broad range of areas, focusing on both cost saving

and cash generating opportunities

Establishment ofa transformation office and investment inICT systems to

improve efficiency and productivity

Oceania has launched a company wide programme to improve both financial

and operational efficiency from FY26

Strengthening the foundations: cost out programme

An Enhancement Plan is in place to improve both operational and financial efficiency during FY26 and supporting strategic priorities.

Overview

Scope

The FY27 target savings range reflects our commitment to operational

efficiency while allowing for strategic investments that support sustainable,

long term cost optimisation

Target Savings Range

Optimisation of the operating model

Targeted cost saving benefits $15 - $20m in total

ItemAnnualised amountFull benefit during

Reduction in professional service fees$5.0mFY26

Right sizing support functions$5.2mFY27

Business optimisation programme$4.8m - $9.8mFY27

$5.0m

$5.2m

$4.8m

$15.0m

$5.0m

$20.0m

Reduction in

professional

service fees

Right sizing

support

functions

Business

optimisation

programme

Targeted cost

saving benefits

(low)

Business

optimisation

programme

Targeted cost

saving benefits

(high)

33
Strengthening the foundations: before launching the strategy

We’re focused on executing our near term enhancement plan, strengthening our core ahead of full strategy rollout.

Address performance and capability pain

points

Execute on operational optimisation plan -

$15 - $20m cost savings

Tighten operational execution to drive

ongoing cashflow improvements

Consolidate and enhance our foundations

Our five year strategy will scale Oceania’s

integrated village model, deepen our care and

living offer, and position the business for

disciplined, long term growth.

Further detail on strategy will be provided

over the coming months

FY26 Enhancement Plan

Strategy - Scale for Growth

Appendices
01Underlying earnings

02Income Statement

03Proforma group underlying earnings

04Cash flow

05Resales cash flow and capital expenditure

06Embedded value and affordability

07Balance sheet

08Future cash recycling

09Portfolio summary

10Future development outlook

11Development pipeline

12Reconciliation of portfolio movements

13Summary of unit sales

14Definition of Underlying NPAT

15Glossary

16Important notice and disclaimer

35
Underlying EBITDA of $86.0m for the 12 month period ended 31 March 2025, 4.1% increase on FY24.

Underlying earnings

Reconciliation of underlying adjustments Segmental underlying adjustments

01

NZDmFY25FY24VarFY23

Reported net profit after tax30.4 31.5 (1.1)15.4

less: Change in fair value of investment property and

impairment of PPE, ROU asset

(64.1)(46.4)(17.7)(13.4)

less: Fair value of loan modification(5.4)- (5.4)-

add: Impairment of goodwill0.2 0.6 (0.4)2.3

add: Realised gains on resales34.8 32.5 2.327.0

add: Realised development margin48.3 35.4 12.9 32.4

less: Deferred tax (4.6)(3.1)(1.5)(3.4)

Add: Care Suite Depreciation11.8 10.3 1.5 9.0

add: Rental expenses in relation to right to use asset - - - 0.2

less: Insurance income on material damage due to

weather events

0.2 0.4 (0.2)(10.0)

add: Other0.9 0.9 (0.1)(0.9)

Underlying NPAT52.5 62.1 (9.6)58.6

add: Depreciation and amortisation (buildings)2.6 2.4 0.22.3

add: Depreciation and amortisation (chattels, leasehold

improvements & software)

7.7 6.2 1.6 6.6

add: Finance costs23.1 11.9 11.212.6

Underlying EBITDA86.0 82.6 3.4 80.0

NZDmFY25FY24VarFY23

Aged Care20.422.0(1.6)20.5

Retirement Village96.484.811.683.0

Other(30.9)(24.2)(6.6)(23.5)

Underlying EBITDA86.082.63.480.0

Oceania successfully refinanced its banking facilities which resulted in $5.4m of a

gain on loan modification. The $5.4m gain has been removed from Underlying

NPAT in line with our policy to remove fair value adjustments.

36
02

Key valuation assumptions remained largely consistent from FY24 except for moderate increases applied to incoming prices across all typologies.

Income statement

DriversFY25FY24

Investment Property

PPGR – Long Term (low-high)2.50% 3.50% 2.50% 3.50%

PPGR – Short Term (low-high)- 3.00% - 3.00%

Discount Rates (low-high)14.00% 20.00% 14.00% 20.00%

Average Incoming Price - Villas$654,109$634,427

Average Incoming Price - Apartments$1,080,126$1,023,612

Property, Plant and Equipment

Cap rate (low-high)12.25%15.00%12.25%17.50%

EBITDAR per bed (low-high, $000's)$9,305$52,060$9.55$56.95

Average Incoming Price - Care Suites$365,620$340,241

NZDm

FY25FY24VarFY23

Operating revenue260.6265.5(4.9)247.2

Change in fair value of investment property90.260.829.421.4

Other Revenue4.99.2(4.3)17.4

Total Income355.7335.420.3286.0

Operating expenses (260.6)(256.7)(3.9)(231.3)

Rental expenditure in relation to ROU Asset0.00.00.0(0.2)

Impairment of goodwill(0.2)(0.6)0.4(2.3)

Impairment of property, plant and equipment(26.0)(14.4)(11.6)(8.0)

Total Expenses

(286.8)(271.6)(15.2)(241.7)

Operating Profit

68.863.85.044.2

Finance costs(20.8)(16.4)(4.4)(14.3)

Depreciation (buildings)(14.4)(12.8)(1.6)(11.4)

Depreciation and amortisation (chattels and other)

(7.7)(6.2)(1.5)(6.6)

Profit / (Loss) before Income tax

25.928.4(2.5)12.0

Taxation benefit/(expense)4.63.11.53.4

Reported Net Profit / (Loss) after Tax

30.431.5(1.1)15.4

Other Comprehensive Income

44.139.05.119.1

Total Comprehensive income

74.670.54.134.5

•Discount rate assumptions are unchanged from FY24.

•Continued moderate increases on average in incoming price assumptions adopted by CBRE for

villas, apartments and care suites

Summary of income statement Key IP and PP&E CBRE valuation assumption changes

37
03

1. Including: Takanini (sold), Holmwood (sold), Middlepark (sold), Victoria Place (sold), Totara Park (sold).

2. No adjustment has been made in relation to acquisitions or development sites..

3. Including sites in footnote 1, plus Amberwood (sold), Greenvalley Lodge (sold), Everil Orr (lease exited), Wesley (lease exited),

Otumarama (closed).

Proforma group underlying earnings for FY25 of $84.5m. Adjustments include normalising for the impact of divesting, closing and exiting several

sites from our ongoing operations.

Proforma group underlying earnings

NZDmFY25

Divested

Sites

1

Normalised

FY25

Aged care operations20.4(0.5)20.9

Retirement village operations13.20.612.7

Realised gains on resales34.81.433.5

Realised development margin48.3-48.3

Corporate(30.9)-(30.9)

Group Proforma Underlying EBITDA

2

86.01.584.5

Group Proforma Underlying NPAT

2

52.51.547.9

Villa and apartment resales 1304126

Villa and apartment new sales97-97

Care suite resales206-206

Care suite new sales87-87

Total sales volume5204516

Group proforma Underlying EBITDA and NPAT (FY25)

Group proforma Underlying EBITDA and NPAT (FY24)

3

NZDmFY24

Divested

Sites

3

Normalised

FY24

Care

21.91.820.0

Village Operations

16.9(0.3)17.2

Resales Capital Gains

32.51.630.9

Development Margin

35.4-35.4

Corporate

(24.0)-(24.0)

Group Proforma Underlying EBITDA

2

82.63.179.5

Group Proforma Underlying NPAT

2

62.13.059.1

Villa and apartment resales

1294125

Villa and apartment new sales

89-89

Care suite resales

1907183

Care suite new sales

68-68

Total sales volume

47611465

In the last 24 months to 31 March 2025 several sites have been exited, closed and divested

1,3

. We show here the unaudited Underlying Earnings attributed to these sites over the current and prior

comparative period. We present unaudited Proforma Underlying Earnings Before Interest, Tax, Depreciation and Amortisation, and Proforma Underlying Net Profit After Tax for both periods,

normalising for the impact of closing, exiting and divesting of these sites from our ongoing operations. Both of these measures are Non-GAAP and unaudited.

Summarised care P&L of sold and exited sites

(NZDm)

FY25

1

FY24

3

Aged care operating revenue4.4 25.5

Aged care expenses (4.9) (23.7)

Underlying care EBITDA(0.5) 1.8

38
04

1. Restated in prior periods, this restatement increases Operating Cashflow from $70.2m to 78.8m in March 2023 and $85.4m to $103.4 in March 2024. Refer to note 1.2(ii) of financial statements.

Operating cash flow of $110.3m for the 12 months to FY25 compared to $103.4m in relation to FY24.

Cash flow

Statement of cash flows

NZDmFY25FY24VarFY23

Receipts from customers201.0207.9(6.9)196.7

Payments to suppliers and employees(266.0)(241.5)(24.5)(220.3)

Rental payments in relation to right of use investment

property

---(0.2)

Receipts from new ORA294.5226.368.2178.8

Payments for outgoing ORA(106.6)(78.8)(27.8)(79.3)

Net goods and services tax received / (paid)(1.9)(3.7)1.814.6

Receipts from insurance proceeds4.78.7(4.0)1.1

Interest received3.14.5(1.4)1.8

Interest paid on general borrowings(18.5)(20.0)1.5(14.4)

Net cash inflow from operating activities

1

110.3103.46.978.8

Proceeds from sale and / or disposal of PP&E and IP32.120.411.70.0

Interest Paid in relation to development borrowings(18.5)(18.0)(0.5)(8.6)

Payments for PPE, intangible assets and assets held

for sale

(39.8)(52.0)12.2(55.2)

Payments for investment property and investment

property under development

(73.7)(128.4)54.7(103.6)

Payments for assets held for sale(0.4)(1.2)0.8(0.9)

Payment for business assets---(59.9)

Net cash outflow from investing activities(100.3)(179.2)78.9(228.2)

Proceeds from borrowings102.0138.7(36.7)228.2

Repayment of borrowings(110.4)(53.9)(56.5)(54.3)

Capitalised borrowing costs---(2.2)

Dividend paid0.0(6.8)6.8(21.8)

Principal Payment for lease liabilities(1.5)(2.1)0.6(2.8)

Net cash inflow from financing activities (9.9)75.9(85.8)147.1

Net increase in cash and cash equivalents0.10.00.1(2.3)

Cash and cash equivalents at beginning of the

period

7.57.40.19.7

Cash and cash equivalents at end of the period7.67.50.17.4

Net cashflows from operating activities

1

NZDm

78.8

103.4

110.3

FY23FY24FY25

39
05

1. Net Buybacks is the difference between the gross ORA payments made in relation to units bought back (and not resold) during the year and the gross ORA receipts from units resold during the year that were bought back in prior financial years.

Growth in resales cash flows as Oceania’s portfolio matures and resells at higher price points.

Reconciliation of resales cash flow and capital expenditure

Reconciliation of resales cash flow

•Net resales cashflow for FY25 of $50.6m, 1.4% up vs. FY24.

•This is driven by 30% greater New ORA receipts, offset by payments for outgoing ORA’s

increasing by 35% and cash inflows for new sales also increasing by 41% YoY.

•Buybacks include the closed building at The Oaks and at Elmwood relating to villas which have

been ear marked for redevelopment.

Breakdown of Capital Expenditure

NZ$mFY25FY24

Acquisitions8.7 24.5

Development capital expenditure102.2136.3

Care suite conversions0.2 -

Maintenance capital expenditure

- Care Suite refurbishment1.81.8

- Other aged care4.1 3.9

- Village refurbishment11.0 7.3

- Other retirement village2.6 2.2

- IT and other1.8 5.5

Total refurbishment and maintenance21.320.8

Total capex per statutory cashflow statement132.4 181.6

NZD $m’sFY25FY24

Receipts from New ORAs

294.5

226.3

less: Payments for Outgoing ORAs

(106.6)

(78.8)

less: Cash Inflow From New Sales

(137.4)

(97.6)

Net Resales Cash flow

50.6

49.9

Made up of :

Resale Gains35.432.5

DMF Realised32.228.1

Add: Net Deferred Cash Settlements5.6(15.8)

less: Development Buybacks(6.5)(12.3)

less: Net Buybacks(15.5)17.2

less: Resident Share of Capital Gains (1.2)(1.1)

less: Other Cash amounts paid/received from resales0.51.4

Net Cash flows from Resales 50.649.9

40
06

1. Calculated as the current / estimated sale or resale price of all units / care suites as determined by CBRE.

2. Value of unsold stock represents the sales prices of units / care suites which are not under contract, as they are either newly constructed or have been bought back from the previous outgoing residents.

The embedded value in our portfolio has increased 14.4% since FY24 to $591.0m as at FY25 and will underpin the future realisation of cash flows

from deferred management fees and resale gains.

CBRE embedded value and affordability ratio

Summary of Embedded Value Calculation

Embedded Value

NZDm

•Embedded value in Oceania’s portfolio is $591.0m, up 14.4% since FY24.

•Embedded value includes:

•$293m of accrued DMF cash flows to be realised; and

•$298m of resale gains.

•The growth in embedded value reflects growth in our portfolio, migration to our standard

contractual terms at existing villages and a higher price point for the sale and resale of units and

care suites.

NZ$m

FY25 FY24 FY23

Estimated sale / resale price of all Units2,042.7 1,861.2 1,703.5

less: Unsold stock(392.2)(395.6)(409.0)

less: Resident liabilities (contractual)(1,059.4)(948.8)(835.8)

equals: Embedded value591.0 516.8 458.7

Average CBRE affordability ratio of Oceania residences

293.0 261.1

298.0

255.7

591.0

516.8

2,366

2,280

-

700

1,400

2,100

2,800

3,500

-

100

200

300

400

500

600

FY25FY24

Accrued DMFEmbedded Resales GainsNumber of units (rhs)

73.4%

80.6%

34.6%

VillasApartmentsCare Suites

41
Netadjustedvalue(“NAV”)

Balance sheet

NZ$m

FY25FY24

Assets

Cash and trade receivables126.1135.4

Property, plant and equipment828.5770.9

Investment properties1,972.01,815.4

Assets held for sale(0.0)44.3

Intangible assets4.75.7

Right of use assets9.410.6

Total assets2,940.72,782.3

Liabilities

Trade, other payables and provisions36.452.1

Deferred management fees 57.347.3

Refundable occupation right agreements1,106.81,004.8

Borrowings627.7640.5

Lease liabilities10.611.2

Total liabilities1,838.81,755.9

Equity

Contributed Equity716.0716.0

Retained Deficit7.0(34.3)

Reserves378.8344.8

Total equity1,101.81,026.5

Net tangible assets1,097.11,020.8

07

Total assets increased by $158m from 31 March 2024. Oceania’s net adjusted value is $1.43 per share as at 31 March 2025.

Balance sheet

•Current headroom in bank facilities (plus cash) of $97m.

•The NAV reflects the value of existing sites, plus the land and WIP at development sites. As

such, the present value of net development cash flows and future earnings at development sites

are excluded.

NZ$m

FY25FY24

PP&E (inc WIP)828.5770.9

IP & ROU Assets (incl WIP)1,981.41,826.2

Held for Sale(0.0)44.3

Sub Total2,809.92,641.3

less ORA Gross Up(913.1)(820.7)

add: Adj for CBRE –Care Suites(197.3)(168.3)

add: Other(33.6)38.4

CBRE plus WIP1,665.81,690.6

less: Net Debt(628.0)(636.5)

Net Adjusted Value1,037.81,054.2

Shares on Issue724.2724.2

Net Adjusted Value per Share1.431.46

42
08

225.0

341.8

102.7

271.9

122.6

496.9

567.1

Development Related DebtUnderlying Development Assets

BondsUnsold StockWIPDevelopment debtDevelopment LandTotal

1.Development debt excludes Oceania’s general / corporate facility but includes corporate bonds and accrued

capitalised interest. The cost of constructing 44 care suites (which are occupied by ORA transfers) at Elmwood has

been removed as they are not included as development assets. $15m has also been reduced to reflect the proceeds

from new sales which were used to repay facility A/core debt during FY25.

2.The WIP balance has been adjusted to include GST, capitalised interest and chattels as per prior reporting periods.

Oceania’s debt is primarily development related, supported by current and future new sales stock, providing a clear path to debt repayment.

Development debt

1

to underlying development assets

2

(NZDm)

•Our development assets remain at 114% of development debt

1,2

at Mar-

25, compared to 115% at Mar-24

•100% of bonds included as ‘development debt’ although $25m was used

to paydown facility A in Oct-21

•No change to value of unsold stock at The Helier

•Higher density, lower development margin completions in recent years

has contributed to reduced asset to debt coverage

•The value of development debt has been adjusted to exclude the

development cost of 44 ORA residents at Elmwood, and $15m of

proceeds from new sales which were used to repay facility A since Mar-

24

•The value of development land is like for like with FY24, including

divested land bank

•The WIP balance has been grossed up to include GST on the Awatere

and Waterford developments which have been removed following the

change of use to serviced apartments

12

Future cash recycling

43
SiteRegionCare bedsCare suitesVillage unitsTotal

NORTH ISLAND

Bream BayRuakaka- - 83 83

The SandsNorth Shore- 44 64 108

Lady AllumNorth Shore- 113 129 242

Te ManaNorth Shore46 - - 46

WaterfordWaitakere- - 150 150

The HelierSt Heliers- 32 79 111

Remuera RiseRemuera12 - 58 70

EdenMt Eden- 65 89 154

MeadowbankMeadowbank- 63 193 256

Elmwood

1

Manukau15 106 129 250

St Johns AucklandManukau- - 18 18

FranklinFranklin44 - - 44

AwatereHamilton- 90 171 261

WhitiangaWhitianga53 - 10 63

ElmswoodTauranga38 - - 38

The BayViewTauranga- 81 162 243

OhinemuriPaeroa68 - 8 76

St Johns WoodTaupo38 40 6 84

WharerangiTaupo47 - 21 68

DuartHastings66 - - 66

EversleyHastings50 - 6 56

GracelandsHastings77 11 119 207

AtawhaiNapier55 28 46 129

Woburn

2

Hawke's Bay33 - - 33

EldonParaparaumu80 15 - 95

EldersleaUpper Hutt102 22 12 136

HeretaungaUpper Hutt38 20 - 58

Hutt GablesUpper Hutt- - 46 46

SiteRegionCare bedsCare suitesVillage unitsTotal

SOUTH ISLAND

Marina CovePicton- - 26 26

Green GablesNelson- 61 40 101

StokeNelson- - 124 124

RedwoodBlenheim17 73 46 136

WoodlandsTasman23 34 36 93

Palm GroveChristchurch28 57 32 117

The OaksChristchurch69 36 32 137

The BellevueChristchurch- 71 68 139

AddingtonChristchurch69 28 - 97

TOTAL (NORTH AND SOUTH ISLANDS)

1068109020034161

09

Asat31 March2025.

Portfolio summary

1.15 beds in the old care building remain occupied as at 31 March 2025.

2.Woburn settled 13 May 2025.

44
Care bedsCare suitesILUsTotal

North Island8627301,5993,191

South Island206360404970

Total Existing1,0681,0902,0034,161

Development Pipeline-5187661284

Less Decommissions

(111)-(52)(163)

Care Suite Conversions

----

Net Development Pipeline

(111)5187141121

Total Post Development

9571,6082,7175,282

10

1. As at 31 March 2025.

68% of our existing portfolio is now premium units and care suites as we progress to ~75% premium / ~25% standard at the end of our current

pipeline.

Future development outlook

Current& futureportfoliocomposition

1

Existingportfolio

Development pipeline

Postdevelopmentportfolio

26%

26%

48%

2,003

RV units

1,068

Care

Beds

1,090

Care

Suites

40%

60%

766

RV Units

518

Care

Suites

5%

43%

52%

663

Planned

550

Consented

71 Under

Construction

32%

68%

2,821

Premium

1,340

Standard

18%

31%

51%

2,717

RV units

957

Care Beds

1,608

Care

Suites

22%

78%

4,105

Premium

1,177

Standard

45
Status as at 31 March 2025.

SitesStageStatusILUsCare suitesGross unitsNet units

Meadowbank

Stage 6

Under Construction

4040

40

Franklin

Stage 1

Under Construction

3131

31

Stage 2-6

Consented

14581226

179

Lady Allum

Stage 2

Consented

6969

69

Stage 3

Consented

6868

68

The BayView

Stages 4-6

Consented

107107

107

EversleyConsented

5858

52

Bream Bay

Stage 1

Consented

2222

23

Stage 2

Planned10760167167

Waterford

Stage 2

Planned

6060

60

GracelandsPlanned

7080150

62

Elmwood

Stage 2-3

Planned

2828

28

Stage 4+

Planned

7676

76

Other

DuartPlanned

264672

72

EldonPlanned

5353

31

StokePlanned171717

BayviewPlanned404040

Total Consented / under construction

442179621568

Total Pipeline76651812841121

11

Development pipeline

46
As at

FY24

Changes

in existing

capacity

Conversion

of beds to

care suites

Conversion

of units to

care suitesNew units acquired

New units

delivered

Changes in

pipeline – gross

units added

Changes in

pipeline –

decommissions

As at

FY25

Existing

Care beds1,396(328)

1068

Care suites1,071(87)106

1090

Units1,915(30)118

2003

Pipeline

Care beds(164)53

(111)

Care suites495(106)10128

518

Units967(118)(144)9

714

Total5,680(445)----(43)90

5282

12

Totals as at 31 March 2025 reconcile to both the total existing and future post development portfolios at appendix 09.

Reconciliation of portfolio movements

Movements in gross pipeline since FY24

1,571

1,284

150 Units

52 Units

(106) Units

(68) Units

(50) Units

(206) Units

(18) Units

(41) Units

FY2024Gracelands - additional

land

Bream Bay

masterplanning update

Elmwood- CompletedAwatere -

completed

Waterford-

completed

Elmwood

masterplanning update

DivestmentsOther net

movements

FY2025

47
Resales

FY21FY22FY23FY24FY25

Villa

5455538267

Apartment

3437454763

Care suite

124174182190206

Total

212266280319336

Average resale margin

22.0%21.2%21.5%21.2%20.3%

New Sales

FY21FY22FY23FY24FY25

Villa

4026080

Apartment

6792548197

Care suite

11566746887

Total

222184128157184

Average development margin

26.1%28.0%37.6%31.1%35.5%

Average resale gain per unit / care suite

FY21FY22FY23FY24FY25

Villa

140,398184,245199,455200,335217,075

Apartment

102,40966,33867,400130,42171,683

Care suite

22,06614,41721,31919,02933,306

Average resale gain

89,42788,31596,399101,792105,220

13

Summary of unit sales

48
14

Definition of Underlying NPAT

Underlying Profit (or Underlying NPAT)

Underlying Profit is a non-GAAP measure used by the Group to monitor financial performance and is a

consideration in determining dividend distributions. Underlying profit measures require a methodology

and a number of estimates to be approved by Directors in their preparation. Both the methodology and

the estimates may differ among companies in the retirement village sector that report underlying

financial measures. Underlying profit is a measure of financial performance and does not represent

business cash flow generated during the period.

Oceania calculates Underlying Profit by making the following adjustments to Net Profit after Tax:

•Removing the change in fair value of investment properties (including right of use investment

property assets) and any impairment or reversal of impairment of property, plant and equipment;

•Removing any impairment of goodwill;

•Removing any gains or loses from the sale or decommissioning of assets;

•Removing any rental expenditure in relation to right of use investment property assets;

•Adding back the Directors’ estimate of realised gains on resale of occupation right agreement units

and care suites;

•Adding back the Directors’ estimate of realised development margin on first sale of new ORA units or

care suites following the development, or conversion of an existing care bed to a care site or

conversion of a rental unit to an ORA Unit;

•Adding back depreciation on care suites; and

•Adding back the deferred taxation component of taxation expense so that only current tax expense is

reflected.

Resale Gain

Directors’ estimate of realised gains on resales of ORA units and care suites (i.e. the difference

between the incoming residents ORA licence payment and the ORA licence payment previously

received from the outgoing resident) is calculated as the net cash flow received, and receivable, at the

point that the ORA contract becomes unconditional and has either ‘cooled off’ or where the resident is in

occupation at balance date.

Development Margin

The Directors’ estimate of realised development margin is calculated as the cash received, and

receivable, in relation to the first sale of new ORA units and care suites, at the point that the ORA

contract becomes unconditional and has either ‘cooled off’ or where the resident is in occupation at

balance date, less the development costs associated with developing the ORA units and care suites.

•Construction costs directly attributable to the relevant project, including any required infrastructure

(e.g. roading) and amenities related to the units (e.g. landscaping) as well as any demolition and site

preparation costs associated with the project. The costs are apportioned between the ORA units and

care suites, in aggregate, using estimates provided by the project quantity surveyor. The construction

costs for the individual ORA units or care suites sold are determined on a pro-rated basis using gross

floor areas of the ORA units and care suites;

•An apportionment of land valued based on the gross floor area of the ORA units and care suites

developed. The value for Brownfield development land is the estimated fair value of land at the time

a change of use occurred (from operating as a care facility or retirement village to a development

site), as assessed by an external independent valuer. Greenfield development land is valued at

historical cost; and

•Capitalised interest costs to the date of project completion apportioned using the gross floor area of

ORA units and care suites developed.

Development costs do not include:

•Construction, land (apportioned on a gross floor area basis) and interest costs associated with

common areas and amenities or any operational or administrative areas.

The Directors’ estimate of development margin for conversions of care beds to care suites and rental

units to ORAs is calculated based on the difference between the ORA licence payment received on the

settlement of sales of newly converted ORA units and care suites and the associated conversion costs.

Conversion costs comprise:

•In the case of conversion of care beds to care suites, the actual refurbishment costs incurred; and

•In the case of conversions of rental units to ORA units, the actual refurbishment costs incurred and

the fair value of the rental unit prior to conversion.

49
15

Glossary

ARCC

Aged Residential Care Contract

Care suite

A room or studio certified for the provision of care by the Ministry of Health which has been licensed

under an ORA.

DMF

Deferred Management Fees, charged under an ORA, of a maximum of 30% of the Occupation Licence

Payment, which are deducted from the refund paid to the departing resident upon resale of the unit or

care suite. These are in consideration for the right to use communal facilities etc over the entire length

of stay.

EBITDA

Earnings Before Interest, Tax, Depreciation and Amortisation

FYXX

12 month audited financial year.

ILU

Independent living units (villas and apartments) licensed under an ORA.

IP

Investment Property.

IPO

Initial Public Offering (of shares in Oceania).

NPAT

Net Profit After Tax.

ORA

An occupation right agreement that confers on a resident the right to occupy a unit or care suite subject

to certain terms and conditions set out in the agreement.

PAC

Premium accommodation charge on a care bed for accommodation provided above the mandated

minimum.

pcp20XX

Prior corresponding periods.

PPE

Property, Plant and Equipment.

PPGR

Property Price Growth Rate.

Resale Margin

Resale gain, as included in the definition of underlying profit, divided by the ORA licence payment

previously received from the outgoing resident.

Unit

Includes independent villas and apartments.

WIP

Work in progress.

50
16

Important notice and disclaimer

This presentation has been prepared solely by Oceania Healthcare Limited ("Oceania"). You

must read this disclaimer before making any use of this presentation and the accompanying

material or any information contained in it ("Document").

The presentation includes non-GAAP financial measures for development sales and resales

which assist the reader with understanding the volumes of units settled during the period and

the impact that development sales and resales during the period had on occupancy as at the

end of the period.

The addition of totals and subtotal within tables and percentage movements may differ due to

rounding.

The information set out in this Document is an overview and does not contain all information

necessary to make an investment decision. It is intended to constitute a summary of certain

information relating to the performance of Oceania for the period ending 31 March 2025.

Please refer to the Interim Financial Statements for the period ended 31 March2025 that

have been released along with this presentation.

The information in this presentation does not purport to be a complete description of Oceania.

In making investment decisions, investors must rely on their own examination of Oceania,

including the merits and risks involved. Investors should consult their own legal, tax and/or

financial advisors in connection with any acquisition of financial products.

The information contained in this presentation has been prepared in good faith by Oceania.

No representation or warranty, expressed or implied, is made to the accuracy, adequacy or

reliability of any statements, estimates or opinions or other information contained in this

presentation, any of which may change without notice. To the maximum extent permitted by

law, Oceania, its directors, officers, employees and agents disclaim all liability and

responsibility (including without limitation any liability arising from fault or negligence on the

part of Oceania, its directors, officers, employees and agents) for any direct or indirect loss or

damage which may be suffered by any person through the use of or reliance on anything

contained in, or omitted from, this presentation.

This presentation is not a product disclosure statement, prospectus, investment statement or

disclosure document, or an offer of shares for subscription, or sale, in any jurisdiction.

Receipt of this Document and/or attendance at this presentation constitutes acceptance of the

terms set out above in this disclaimer.

---

Results announcement
(for Equity Security issuer/Equity and Debt Security issuer)

Updated as at March 2025



Results for announcement to the market

Name of issuer Oceania Healthcare Limited

Reporting Period 12 months to 31 March 2025

Previous Reporting Period 12 months to 31 March 2024

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$260,572 (2%)

Total Revenue $260,572 (2%)

Net profit/(loss) from

continuing operations

$30,415 (3%)

Total net profit/(loss) $30,415 (3%)

Interim/Final Dividend

Amount per Quoted Equity

Security

It is not proposed to pay dividends.

Imputed amount per Quoted

Equity Security

Not applicable

Record Date Not applicable

Dividend Payment Date Not applicable

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security (in

dollars and cents per

security)

$1.51 $1.41

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Please refer to attached documents (consolidated financial

statements and annual report, media release and results

presentation).

Authority for this announcement

Name of person


authorised

to make this announcement

Claire Fisher

Contact person for this

announcement

Claire Fisher

Contact phone number 0800 333 002

Contact email address claire.fisher@oceaniahealthcare.co.nz

Date of release through MAP


22 May 2025


Audited financial statements accompany this announcement.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.